Frederick Wayne Holtsberg

Integrated Biotherapeutics, Inc.

$3,471,449

Attributed

$5,117,306

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY2014–22

$2.5M$1.9M$1.3M$625K$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$5,117,306 · 5

By mechanism

R44$3,825,589 · 2

R41$1,291,717 · 3

Top collaborators

Most similar at Integrated Biotherapeutics, Inc.

Same institution · by research overlap

Shweta Kailasan$1,196,627
Kelly Lyn Warfield$750,000

Others in their field

Top investigators on “Cessation Of Life”

David R. Weir · University Of Michigan At Ann Arbor$345,522,974
John M Lachin · George Washington University$134,302,892
David M Nathan · Massachusetts Institute Of Technology$127,791,564
Judith S Hochman · New York University School Of Medicine$112,898,313
Jeffrey H Samet · Boston University Medical Campus$91,739,367
Judith S. Currier · University Of California Los Angeles$85,330,415

Research focus

Cessation Of LifeBaseIn VivoLeadPharmaceutical PreparationsAnimal ModelMouse ModelCommercializationIn VitroVirusAntibodiesClinical DevelopmentSpecificityProductionManufacturing ProcessResistanceHourClinical ResearchMonoclonal AntibodiesPositioning AttributeDisease OutbreaksLegal PatentDoseLight